Douglas Ingram

Douglas Ingram

Chief Executive Officer at SAREPTA THERAPEUTICS, INC.

Net worth: 12 M $ as of 2026-05-30

63 year
Health Technology
Finance
Consumer Services

Profile

Douglas S. Ingram occupies the position of President, Chief Executive Officer & Director at Sarepta Therapeutics, Inc. He is also on the board of Allergan Foundation and Relay Therapeutics, Inc. He previously held the position of Attorney at Gibson, Dunn & Crutcher LLP, Chief Executive Officer & Director at Chase Pharmaceuticals Corp. and President for Allergan, Inc. Mr. Ingram received an undergraduate degree from Arizona State University and a graduate degree from the University of Arizona.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-07 390,307 ( 0.37% ) 7 M $ 2026-05-30
2026-01-14 59,016 ( 0.04% ) 5 M $ 2026-05-30
2026-06-08 25,000 ( 0.01% ) 351 250 $ 2026-05-30

Douglas Ingram active positions

CompaniesPositionStart
SAREPTA THERAPEUTICS, INC. Chief Executive Officer 2017-06-25
RELAY THERAPEUTICS, INC. Director/Board Member 2019-05-31
Allergan Foundation
Director/Board Member -

Former positions of Douglas Ingram

CompaniesPositionEnd
ARROWHEAD PHARMACEUTICALS, INC. Director/Board Member 2026-03-18
Director/Board Member 2018-04-30
SKYE BIOSCIENCE, INC. Director/Board Member 2018-01-18
ENDO INTERNATIONAL PLC Director/Board Member 2017-11-05
Chief Executive Officer 2016-10-31
See the detail of Douglas Ingram's experience

Training of Douglas Ingram

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

80

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Health Technology

Commercial Services

Health Technology

Health Technology

Finance

Finance

Consumer Non-Durables

Health Technology

Health Technology

Consumer Services

Consumer Services

Finance

Allergan Foundation

Health Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Douglas Ingram